Drug therapy
Gene-based drug therapy for children and youth treated with psychoactive medications
Posted: Feb 14, 2024
Committee(s): Drug Therapy Committee
Topic(s): community paediatrics, mental health, genetics, drug therapy
The management of very mild and mild asthma in preschoolers, children, and adolescents
Posted: Dec 8, 2023
Committee(s): Respiratory Health Section
Topic(s): asthma, drug therapy, respirology, community paediatrics
Gene-based drug therapy in children
Posted: Mar 3, 2023
Committee(s): Drug Therapy Committee
Topic(s): genetics, drug therapy
Managing critical drug shortages in clinical practice
Posted: Dec 1, 2022
Committee(s): Drug Therapy Committee
Topic(s): drug therapy, emergency medicine, infectious diseases
The management of infants, children, and youth at risk for hepatitis C virus (HCV) infection
Posted: Nov 5, 2021
Committee(s): Infectious Diseases and Immunization Committee
Topic(s): adolescent health, infectious diseases, risky behaviours, fetal and maternal issues, social paediatrics, newborn medicine, drug therapy
Recommendations for procedural sedation in infants, children, and adolescents
Posted: Mar 12, 2021
Committee(s): Acute Care Committee, Drug Therapy Committee
Topic(s): acute care, drug therapy
The use of oral opioids to control children’s pain in the post-codeine era
Posted: Mar 12, 2021
Committee(s): Drug Therapy Committee
Topic(s): drug therapy, hazardous substances
Post-diagnostic management and follow-up care for autism spectrum disorder
Posted: Oct 24, 2019
Committee(s): Autism Spectrum Disorder Guidelines Task Force
Topic(s): autism, developmental paediatrics, complementary and alternative medicine, drug therapy
Pharmacare in Canada: The Paediatric Perspective
Posted: Sep 26, 2019 | Reaffirmed: Jan 12, 2026
Committee(s): Paediatric Drugs and Therapeutics Task Force
Topic(s): advocacy, drug therapy
Improving paediatric medications: A prescription for Canadian children and youth
Posted: Jul 25, 2019 | Reaffirmed: Jan 12, 2026
Committee(s): Paediatric Drugs and Therapeutics Task Force
Topic(s): drug therapy, advocacy
Disclaimer: The recommendations in this position statement do not indicate an exclusive course of treatment or procedure to be followed. Variations, taking into account individual circumstances, may be appropriate. Internet addresses are current at time of publication.